Phase II evaluation of dihydroxyanthracenedione (DHAD), (NSC 301739) for gastric (G) and pancreatic (P) cancer

J. R. Stroehlein, A. Y. Bedikian, D. A. Karlin

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	C-366
Journal	Proceedings of the American Society of Clinical Oncology
Volume	Vol. 1
State	Published - 1982

ASJC Scopus subject areas

@article{4c16987bf46f4553868cd665dcda923b,

title = "Phase II evaluation of dihydroxyanthracenedione (DHAD), (NSC 301739) for gastric (G) and pancreatic (P) cancer",

author = "Stroehlein, {J. R.} and Bedikian, {A. Y.} and Karlin, {D. A.}",

year = "1982",

language = "English (US)",

volume = "Vol. 1",

pages = "C--366",

journal = "Proceedings of the American Society of Clinical Oncology",

}

TY - JOUR

T1 - Phase II evaluation of dihydroxyanthracenedione (DHAD), (NSC 301739) for gastric (G) and pancreatic (P) cancer

AU - Stroehlein, J. R.

AU - Bedikian, A. Y.

AU - Karlin, D. A.

PY - 1982

Y1 - 1982

UR - http://www.scopus.com/inward/record.url?scp=17944400078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944400078&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:17944400078

VL - Vol. 1

SP - C-366

JO - Proceedings of the American Society of Clinical Oncology

JF - Proceedings of the American Society of Clinical Oncology

ER -